Skip to main content
. 2021 Sep 13;28(1):1836–1848. doi: 10.1080/10717544.2021.1965675

Figure 2.

Figure 2.

In vitro drug release profiles of natamycin (NT) from F1 (optimized NT-Cub dispersed in Carbopol 934 in situ gel base), F2 (optimized NT-Cub dispersed in phosphate buffer pH 5.5), F3 (NT powder dispersed in Carbopol 934 in situ gel base), and NT suspension samples.